266 related articles for article (PubMed ID: 21484335)
21. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
22. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
23. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
Kahrilas PJ; Fennerty MB; Joelsson B
Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
[TBL] [Abstract][Full Text] [Related]
24. [Medication therapeutic strategies for gastro-esophageal reflux disease].
Labenz J; Leodolter A
Z Gastroenterol; 2007 Nov; 45(11):1169-79. PubMed ID: 18027319
[TBL] [Abstract][Full Text] [Related]
25. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
[TBL] [Abstract][Full Text] [Related]
26. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
[TBL] [Abstract][Full Text] [Related]
27. Evolving issues in the management of reflux disease?
Yuan Y; Hunt RH
Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
[TBL] [Abstract][Full Text] [Related]
28. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
29. Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.
Tonini M; Vigneri S; Neri M; Cuomo R; Savarino V; Pace F
Digestion; 2007; 76(3-4):171-8. PubMed ID: 18046084
[TBL] [Abstract][Full Text] [Related]
30. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
[TBL] [Abstract][Full Text] [Related]
31. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease.
Gold BD; Pilmer B; Kierkuś J; Hunt B; Perez MC; Gremse D
Dig Dis Sci; 2017 Nov; 62(11):3059-3068. PubMed ID: 28916953
[TBL] [Abstract][Full Text] [Related]
32. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
33. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
Hershcovici T; Fass R
Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
[TBL] [Abstract][Full Text] [Related]
34. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
von Renteln D; Brey U; Riecken B; Caca K
Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
[TBL] [Abstract][Full Text] [Related]
36. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
37. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of proton pump inhibitors in nonerosive reflux disease.
Dean BB; Gano AD; Knight K; Ofman JJ; Fass R
Clin Gastroenterol Hepatol; 2004 Aug; 2(8):656-64. PubMed ID: 15290657
[TBL] [Abstract][Full Text] [Related]
39. Management of heartburn not responding to proton pump inhibitors.
Fass R; Sifrim D
Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy and safety of OTC omeprazole].
Labenz J; Willmer C
MMW Fortschr Med; 2012 Dec; 154 Suppl 4():110-4. PubMed ID: 23326929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
